Palisade Bio, Inc. (PALI) NASDAQ

0.76

-0.0055(-0.72%)

Updated at May 09 10:17AM

Currency In USD

Palisade Bio, Inc.

Address

5800 Armada Drive

Carlsbad, CA 92008

United States of America

Phone

858 704 4900

Sector

Healthcare

Industry

Biotechnology

Employees

8

First IPO Date

March 30, 2007

Key Executives

NameTitlePayYear Born
Mr. J. D. FinleyChief Executive Officer, Chief Financial Officer & Director813,0001958
Dr. Mitchell Lawrence Jones M.D., Ph.D.Chief Operating Officer & Chief Medical Officer581,0001977
Dr. Joerg Heyer Ph.D.Head of Translational Science & Medicine0N/A
Mr. Ryker WillieSenior Vice President of Finance & Corporate Controller0N/A

Description

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from reduced blood flow to the intestine, infections, or due to surgery. The company was founded in 2005 and is headquartered in Carlsbad, California.